Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1
Authors:
- 1 June 1990
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 64 (6) , 2841-2848
Abstract
We have shown that enzymatic removal of N-linked glycans from human immunodeficiency virus type 1 (HIV-1) recombinant envelope glycoproteins gp160 and gp120 produced in BHK-21 cells did not significantly reduce their ability to bind to CD4, the cellular receptor for the virus. Because recombinant proteins may behave differently from proteins present on virions, we investigated whether such viral envelope glycoproteins either in a purified form or present on viral particles could be deglycosylated by treatment with an endoglycosidase F-N-glycanase mixture which cleaves all accessible glycan moieties. Endoglycosidase analysis of the carbohydrate composition of purified viral gp120 (vgp120) indicated a glycosylation pattern similar to that for recombinant gp120 (rgp120), and treatment with endoglycosidase F-N-glycanase resulted in comparable molecular weight (MW) reduction for both molecules. Similarly, after immunoblotting of the deglycosylated viral preparation, the characteristic 160- and 120-kilodalton (kDa) bands were replaced by 90- and 60-kDa bands, respectively. The apparent MW of gp41 shifted to 35 kDa. These results are consistent with complete deglycosylation. The immunoreactive conformation of envelope glycoproteins remained unaltered after deglycosylation: they were recognized to the same extent by specific human polyclonal or mouse monoclonal antibodies, and no proteolysis of viral proteins occurred during enzymatic treatment. Deglycosylation of vgp120 resulted in a less than 10-fold reduction of the ability to bind to CD4, presented either in a soluble form or at the cell membrane. In addition, deglycosylation significantly reduced, but did not abolish, HIV-1 binding to and infectivity of CD4+ cells as determined, respectively, by an indirect immunofluorescence assay and a quantitative dose-response infection assay. Taken together, these results indicate that removal of glycans present on mature envelope glycoproteins of HIV-1 diminishes but does not abolish either virus binding to CD4 or its capacity to infect CD4+ cells.Keywords
This publication has 33 references indexed in Scilit:
- Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis.Journal of Experimental Medicine, 1989
- Predictions of linear T‐cell and B‐cell epitopes in proteins encoded by HIV‐1, HIV‐2 and SIVMAC and the conservation of these sites between strainsFEBS Letters, 1988
- Operational and Topological Analyses of Antigenic Sites on Influenza C Virus Glycoprotein and Their Dependence on GlycosylationJournal of General Virology, 1988
- EFFECT OF CULTURE SUPERNATANT OF MT‐2 CELLS ON HUMAN IMMUNODEFICIENCY VIRUS‐PRODUCING CELLS, MOLT‐4/HIVHTLV‐IIIB CELLSJapanese Journal of Cancer Research, 1988
- Evidence That Mannosyl Residues Are Involved in Human Immunodeficiency Virus Type 1 (HIV-1) PathogenesisAIDS Research and Human Retroviruses, 1987
- The role of the carbohydrate moiety in thyrotropin actionBiochemical and Biophysical Research Communications, 1985
- Effects of glycosylation on the conformation and antigenicity of influenza C viral glycoproteinsVaccine, 1985
- Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase FBiochemistry, 1985
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970